Advocating for Diverse Representation in Clinical Trials with Ricki Fairley - a podcast by Susan G. Komen

Clinical trials test the safety and benefits of new treatments as well as new combinations (or new doses) of standard treatments. They can also study other parts of care including risk reduction, diagnosis and screening. People volunteer to take part in clinical trials and those who join help further the knowledge base that helps improve breast cancer care. Here today to share the importance of having a wide range of women represented in these clinical trials is Ricki Fairley.

Special Guest: Ricki Fairley.

Sponsored By:

• Amgen Oncology:
  
  At Amgen, we are committed to the relentless pursuit of breakthroughs for cancer patients and their families. We have a deep and diverse pipeline of cutting-edge therapeutic approaches that aim to improve outcomes.
  
  Amgen has been pursuing novel treatment approaches for more than 40 years.
  
  We never stop looking toward the next frontier of innovation to bring the greatest potential benefit to patients.
  

Further episodes of Real Pink

Further podcasts by Susan G. Komen

Website of Susan G. Komen